desired properties of the formulation any number of ingredients may be used alone or in combination based upon their functions such ingredients include but are not limited to buffers diluents binders disintegrants compression aids lubricants flavors sweeteners colorants and preservatives in embodiments the present application is directed to sublingual pharmaceutical formulations comprising zolpidem a buffer a binder a disintegrant and a lubricant and optionally one or more additional agents such as flavoring agents colorants and sweeteners in embodiments the present application is directed to disintegrating formulations comprising zolpidem as an active ingredient a superdisintegrant such as croscarmellose crospovidone or sodium starch glycolate a buffer such as sodium carbonate or meglumine and other desired excipients in embodiments pharmaceutical formulations of the present application have a sublingual disintegration time of about 5 minutes or less or about 2 minutes or less following administration to the mouth in embodiments formulations of the present application undergo disintegration within about 2 10 minutes or about 5 minutes or about 7 minutes following administration to the mouth typically the formulations of the present application comprise less than about 5 mg e g from about 0 5 mg to about 4 75 mg from about 1 5 mg to about 2 5 mg from about 3 0 mg to about 3 75 mg etc of.